Cakir E, Demirag E, Aydin M, Unsal E
Department of Pathology, Ataturk Chest Diseases and Chest Surgery Education and Research Hospital, Ankara, Turkey.
Acta Chir Belg. 2009 Jul-Aug;109(4):489-93. doi: 10.1080/00015458.2009.11680466.
Lung tumours with a mixed histologic pattern are rare. We evaluated the clinicopathologic features and prognosis of lung tumours with mixed histology and compared them with the tumours which have single histology. The study group consisted of 39 patients with a mixed histologic pattern and a control group consisted of 41 patients with a single histology on the consecutive surgical specimens. In the study group three types of tumour were identified: adenosquamous carcinoma, combined neuro-endocrine tumours and biphasic tumours. The combined neuro-endocrine tumours were further divided into small cell carcinoma (SCLC)+non-neuro-endocrine carcinoma (NNEC), SCLC+large cell neuro-endocrine carcinoma (LCNEC) and LCNEC +NNEC. Clinicopathologic characteristics, stage and survival rates were evaluated retrospectively and compared with the tumours showing single histology. There was no significant difference in mean age, sex, smoking history, asbestos exposure and tumour size between the study and control groups (p > 0.05). Among adenosquamous carcinomas advanced stage (IIIa or IIIb) (p = 0.004), vascular invasion (p = 0.04) and parietal pleural involvement (p = 0.012) was significantly more evident than in the single histology group. Among combined neuro-endocrine tumours, advanced stages (p = 0.002) and vascular invasion (p = 0.003) were more evident than in the single histology group. Two- year survival rates were 60% for the single histology group, 39% for the adenosquamous group and 25% for the combined neuro-endocrine tumour group (p = 0.0002). Tumours with mixed histology are rarely seen in the lung. Among these tumours adenosquamous carcinoma and combined neuro-endocrine tumours present more aggressive clinico-pathologic behaviour than tumors with a single histology.
具有混合组织学模式的肺肿瘤很罕见。我们评估了具有混合组织学的肺肿瘤的临床病理特征和预后,并将它们与具有单一组织学的肿瘤进行比较。研究组由39例具有混合组织学模式的患者组成,对照组由41例连续手术标本具有单一组织学的患者组成。在研究组中,识别出三种类型的肿瘤:腺鳞癌、复合性神经内分泌肿瘤和双相肿瘤。复合性神经内分泌肿瘤进一步分为小细胞癌(SCLC)+非神经内分泌癌(NNEC)、SCLC+大细胞神经内分泌癌(LCNEC)和LCNEC+NNEC。对临床病理特征、分期和生存率进行回顾性评估,并与显示单一组织学的肿瘤进行比较。研究组和对照组在平均年龄、性别、吸烟史、石棉暴露和肿瘤大小方面无显著差异(p>0.05)。在腺鳞癌中,晚期(IIIa或IIIb)(p=0.004)、血管侵犯(p=0.04)和脏层胸膜受累(p=0.012)比单一组织学组更明显。在复合性神经内分泌肿瘤中,晚期(p=0.002)和血管侵犯(p=0.003)比单一组织学组更明显。单一组织学组的两年生存率为60%,腺鳞癌组为39%,复合性神经内分泌肿瘤组为25%(p=0.0002)。具有混合组织学的肿瘤在肺中很少见。在这些肿瘤中,腺鳞癌和复合性神经内分泌肿瘤比具有单一组织学的肿瘤表现出更具侵袭性的临床病理行为。